Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 2/20 | 0.71 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.38 |
| ▸ | PKM | P14618 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4426319 | 0.92 | MMP8 (0.76) | MMP8CYP4F2CYP4A11PKMALDH1A1 | |
| SCHEMBL7517743 | 0.82 | MMP8 (0.50) | MMP8ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL7857447 | 0.79 | MMP8 (0.59) | MMP8CYP4F2CYP4A11PKMALDH1A1 | |
| SCHEMBL3343065 | 0.79 | MMP8 (0.48) | MMP8CYP4F2CYP4A11PKMALDH1A1 | |
| SCHEMBL12574780 | 0.78 | MMP8 (0.58) | MMP8CYP4F2CYP4A11PKMALDH1A1 | |
| SCHEMBL2321947 | 0.77 | MMP8 (0.53) | MMP8CYP4F2CYP4A11PKMALDH1A1 | |
| SCHEMBL234014 | 0.77 | MMP8 (0.56) | MMP8CYP4F2CYP4A11PKMALDH1A1 | |
| SCHEMBL9751488 | 0.77 | MMP8 (0.45) | MMP8ALDH1A1 | |
| SCHEMBL334816 | 0.76 | MMP8 (0.56) | MMP8CYP4F2CYP4A11PKMALDH1A1 | |
| SCHEMBL6594108 | 0.76 | MMP8 (0.56) | MMP8CYP4F2CYP4A11PKMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110506234-A | Anti-corrosion agent composition and pattern forming method and compound and resin using it | THE SCHOOL CORPORATION KANSAI UNIV | 2019-11-26 | — | — | CN | disclosed |
| CN-110476122-A | Compound, the anti-corrosion agent composition comprising compound and the pattern forming method using it | THE SCHOOL CORPORATION KANSAI UNIV | 2019-11-19 | — | — | CN | disclosed |
| CN-109803950-A | Compound, resin and composition and corrosion-resisting pattern forming method and circuit pattern forming method | 三菱瓦斯化学株式会社 | 2019-05-24 | — | — | CN | disclosed |
| CN-109790175-A | Compound, resin, composition and corrosion-resisting pattern forming method and pattern forming method | 三菱瓦斯化学株式会社 | 2019-05-21 | — | — | CN | disclosed |
| CN-109073782-A | Optical element forms composition and its solidfied material | 三菱瓦斯化学株式会社 | 2018-12-21 | — | — | CN | disclosed |
| CN-105764892-B | Method for purifying compound or resin | 三菱瓦斯化学株式会社 | 2018-09-25 | — | — | CN | disclosed |
| CN-107848946-A | New (methyl) acryl compound and its manufacture method | 三菱瓦斯化学株式会社 | 2018-03-27 | — | — | CN | disclosed |
| CN-107250089-A | Compound, resin, lower layer film for lithography formation material, lower layer film for lithography form the purification process with composition, lower layer film for lithography, corrosion-resisting pattern forming method, circuit pattern forming method and compound or resin | 三菱瓦斯化学株式会社 | 2017-10-13 | — | — | CN | disclosed |
| CN-105764892-A | Method for purifying compound or resin | 三菱瓦斯化学株式会社 | 2016-07-13 | — | — | CN | disclosed |
| US-8563728-B2 | Process for the preparation of Dutasteride | AUROBINDO PHARMA LTD. (IN) | 2013-10-22 | — | — | US | disclosed |
| US-20120157683-A1 | PROCESS FOR THE PREPARATION OF DUTASTERIDE | AUROBINDO PHARMA LTD (IN) | 2012-06-21 | — | — | US | disclosed |
| WO-2011004242-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF DUTASTERIDE | AUROBINDO PHARMA LIMITED (IN) | 2011-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157683-A1 | PROCESS FOR THE PREPARATION OF DUTASTERIDE | CYP21A2, CYP17A1, HSD17B7 | MMP8 4230/4885CYP4F2 53/4885CYP4A11 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.